[HTML][HTML] CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients
Background COVID-19 has so far affected more than 250 million individuals worldwide, causing
more than 5 million deaths. Several risk factors for severe disease have been identified, …
more than 5 million deaths. Several risk factors for severe disease have been identified, …
CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients (preprint)
Background: COVID-19 has so far affected more than 250 million individuals worldwide,
causing more than 5 million deaths. Several risk factors for severe disease have been identified, …
causing more than 5 million deaths. Several risk factors for severe disease have been identified, …
[HTML][HTML] Concentration of Na+-taurocholate-cotransporting polypeptide expressed after in vitro-transcribed mRNA transfection determines susceptibility of hepatoma …
A Oswald, A Chakraborty, Y Ni, JM Wettengel… - Scientific reports, 2021 - nature.com
Infection of hepatocytes by hepatitis B virus (HBV) depends on surface expression of its
receptor Na + -taurocholate-cotransporting polypeptide (NTCP), but sufficient NTCP expression …
receptor Na + -taurocholate-cotransporting polypeptide (NTCP), but sufficient NTCP expression …
[PDF][PDF] Andreas Oswald1, 5, Anindita Chakraborty1, 5, Yi Ni2, 3, Jochen M. Wettengel1
… The authors thank Siemens Molecular Diagnostics for providing and Philipp Hagen and
Ana-Marija Jetzlsperger for performing HBeAg assays. The study was supported by funds of the …
Ana-Marija Jetzlsperger for performing HBeAg assays. The study was supported by funds of the …
Evaluation of hepatitis B virus surface protein variations in patients under therapy with nucleic acid polymer REP 2139-Ca
H Mijočević - 2020 - mediatum.ub.tum.de
A recent clinical study with nucleic acid polymers (NAP) in patients with chronic hepatitis B
showed a reduction of HBsAg and HBV DNA and seroconversion to anti-HBs indicating a …
showed a reduction of HBsAg and HBV DNA and seroconversion to anti-HBs indicating a …
